- Report
- May 2024
- 129 Pages
Global
From €6196EUR$6,499USD£5,291GBP
- Report
- February 2024
- 106 Pages
Global
From €4529EUR$4,750USD£3,867GBP
From €5673EUR$5,950USD£4,844GBP
From €6197EUR$6,500USD£5,292GBP
- Report
- February 2024
- 150 Pages
Global
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 143 Pages
Global
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 176 Pages
Global
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 120 Pages
Global
From €4529EUR$4,750USD£3,867GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2860EUR$3,000USD£2,442GBP
- Report
- April 2024
- 185 Pages
Global
From €4672EUR$4,900USD£3,989GBP
- Report
- February 2024
- 181 Pages
Europe
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 90 Pages
United States
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 160 Pages
Middle East, Africa
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 90 Pages
Europe
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 70 Pages
United States
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 85 Pages
North America
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4529EUR$4,750USD£3,867GBP
- Report
- February 2024
- 80 Pages
Europe
From €4529EUR$4,750USD£3,867GBP
Humalog is a brand of insulin used to treat diabetes, a chronic endocrine and metabolic disorder. It is a fast-acting insulin that helps to control blood sugar levels in people with type 1 and type 2 diabetes. Humalog is a recombinant human insulin analog, meaning it is a synthetic version of the natural human insulin. It is administered via injection and works by helping the body to use glucose from the bloodstream. Humalog is used to help control blood sugar levels in people with diabetes, and can be used in combination with other diabetes medications.
Humalog is available in a variety of forms, including vials, pens, and cartridges. It is manufactured by Eli Lilly and Company, and is available in many countries around the world. Other companies that produce insulin analogs include Novo Nordisk, Sanofi, and Biocon. Show Less Read more